VIDEO: Cross-linking underway in US since FDA approval

CHICAGO — At the Ophthalmology Innovation Summit here, Avedro's chief medical officer Rajesh K. Rajpal, MD, talks about the company's progress with cornea collagen cross-linking in the U.S. since FDA approval in April 2016, as well as the trials of photorefractive intrastromal cross-linking that are underway outside the U.S.